Pharma Marketing Network

For years, pharmaceutical sampling was largely viewed as a rep-driven transaction. A healthcare professional asked for a product sample, the request was processed, and the sample was delivered. Today, pharma e-sampling is changing how that exchange happens and what marketers can learn from it. When an authenticated HCP actively requests a sample online, the action can reveal ...

Two hospitals may serve the same therapeutic market, treat similar patients, and sit only miles apart. Yet their pharmacy economics and access environments can look remarkably different. For teams building a 340B pharma marketing strategy, that difference is becoming harder to ignore. Contract pharmacy policies, manufacturer restrictions, state protections, litigation, and cl...

Alternative funding programs in pharma were once viewed mainly as a payer issue, but they are becoming a much broader patient-access challenge. These programs can exclude selected specialty drugs from employer-sponsored coverage and then direct patients toward other sources of funding, including manufacturer patient assistance programs (PAPs). In effect, a benefit-design deci...

For decades, pharmaceutical marketers have worked with a fairly familiar customer journey. A patient sees an ad, searches for a condition or branded drug, visits a manufacturer website, talks with a healthcare professional, and eventually reaches a pharmacy. TrumpRx adds something unusual to that path: the federal government.

The implications of this shift go beyond dr...

It’s easy to treat pharma website accessibility as little more than a technical checklist. Yet for patients, the questions are much more basic: Can I read this? Can I hear it? Can I navigate it? Can I understand what I should do next? A pharmaceutical website may have strong creative, useful educational content, and a carefully planned media strategy. However, if patients wit...